B
Bernice Oberman
Researcher at Sheba Medical Center
Publications - 38
Citations - 974
Bernice Oberman is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 30 publications receiving 850 citations.
Papers
More filters
Journal ArticleDOI
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
Ido Wolf,Ido Wolf,Seigal Sadetzki,Hannah Kanety,Yulia Kundel,Clara Pariente,Nava Epstein,Bernice Oberman,Raphael Catane,Raphael Catane,Bella Kaufman,Ilan Shimon,Ilan Shimon +12 more
TL;DR: The hormone ghrelin and the adipocytokines leptin and adiponectin participate in body weight regulation and it is hypothesized that responses of these hormones may be attenuated in cancer cachexia.
Journal ArticleDOI
Uterine leiomyosarcoma: does the primary surgical procedure matter?
TL;DR: In patients with stage I LMS, primary surgery involving tumor injury seems to be associated with a worse prognosis than total hysterectomy as a primary intervention.
Journal ArticleDOI
Smoking and risk of parotid gland tumors: a nationwide case-control study.
Siegal Sadetzki,Siegal Sadetzki,Bernice Oberman,Lori Mandelzweig,Angela Chetrit,Tehila Ben-Tal,Avital Jarus-Hakak,Shay Duvdevani,Elisabeth Cardis,Michael Wolf,Michael Wolf +10 more
TL;DR: The objective of the current study was to assess the association between smoking and benign and malignant parotid gland tumors (PGTs) in a nationwide study.
Journal ArticleDOI
Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer.
Moshe Z. Papa,Douglas Zippel,Douglas Zippel,Bella Kaufman,Shani Shimon-Paluch,Ady Yosepovich,Ady Yosepovich,Bernice Oberman,Siegal Sadetzki +8 more
TL;DR: To address optimal timing of sentinel lymph node biopsy (SLNB) in breast cancer patients undergoing neoadjuvant treatment, data are analyzed to determine the best time to perform the biopsy.
Journal ArticleDOI
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
Ido Wolf,Ido Wolf,Siegal Sadetzki,Siegal Sadetzki,Iris Gluck,Bernice Oberman,Merav A. Ben-David,Moshe Z. Papa,Moshe Z. Papa,Raphael Catane,Raphael Catane,Bella Kaufman +11 more
TL;DR: The results show that diabetes mellitus is associated with negative prognostic factors at breast cancer presentation and breast cancer among diabetic patients was more often hormone receptor negative after adjustment for BMI.